Navigation Links
Panetta Statement on Passing of Duane Roth
Date:8/3/2013

SAN DIEGO, Aug. 4, 2013 /PRNewswire/ -- Joe Panetta, president and CEO of BIOCOM, released the following statement upon news of the passing of Duane Roth, President and CEO of CONNECT:

"I speak for the BIOCOM board, staff, and the entire BIOCOM family in saying the life science industry has lost one of its most devoted champions.  Duane's passion for the industry first as a company executive (with Alliance Pharmaceutical) and later as CONNECT's President and CEO was unwavering.  His contributions to San Diego are not limited to the life science industry, and his loss will be felt throughout our community."

(Logo: http://photos.prnewswire.com/prnh/20130228/LA69104LOGO)

"Personally, I will deeply miss Duane as a friend, colleague, and confidant.  Our lives were intertwined not only professionally but socially and casually as well.  Karin and I extend our deepest sympathies to Renee and the entire Roth family."

Duane Roth was a founding member of the BIOCOM Board of Directors and is the only person to have served two terms as BIOCOM board chair, in 1996-97 and 2004-05.  In 2010, Roth was given the highest honor BIOCOM can bestow on a board member, that of Life Director, a position reserved only to those who have distinguished themselves in service at the highest levels to BIOCOM and the Southern California life science community.


'/>"/>
SOURCE BIOCOM
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Life Technologies Announces Filing of Definitive Proxy Statement
2. Intrexon Announces Filing of Registration Statement For Proposed Initial Public Offering
3. Vermillions OVA1 Receives New Statement by Society of Gynecologic Oncology
4. Royalty Pharma Statement Regarding Elan Law Suits
5. Cellular Dynamics International Files Registration Statement for Proposed Initial Public Offering
6. CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard
7. Regado Biosciences, Inc. Files Registration Statement for Proposed Initial Public Offering
8. Vestiage Announces Filing of Disclosure Statement with Exchange
9. Royalty Pharma Statement Regarding Elan Proposal
10. Ambit Biosciences Files Registration Statement for Proposed Initial Public Offering
11. Statement by Life Technologies Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... Newly created 4Sight Medical ... to the healthcare market. The company's primary focus is on new product introductions, ... strategies that are necessary to help companies efficiently bring their products to market. ...
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young ... cancer. Members of the Class of 2016 were selected from a pool of ... More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology:
(Date:4/19/2016)... DUBAI , UAE, April 20, 2016 ... can be implemented as a compact web-based "all-in-one" system ... in the biometric fingerprint reader or the door interface ... requirements of modern access control systems. The minimal dimensions ... the ID readers into the building installations offer considerable ...
(Date:4/14/2016)... , April 14, 2016 ... and Malware Detection, today announced the appointment of ... the new role. Goldwerger,s leadership appointment comes ... the heels of the deployment of its platform at ... behavioral biometric technology, which discerns unique cognitive and physiological ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys has ... CEO, Barrett Bready , M.D., who returned to ... the original technical leadership team, including Chief Technology Officer, ... Product Development, Steve Nurnberg and Vice President of Software ... the company. Dr. Bready served as CEO ...
Breaking Biology News(10 mins):